ApoA-II kinetics in humans using endogenous labeling with stable isotopes: Slower turnover of apoA-II compared with the exogenous radiotracer method

Journal of Lipid Research

Volumn 37, Issue 2, 1996, Pages 399-407

  Ikewaki, Katsunori ^a,b   Zech, Loren A ^a   Brewer Jr , H Bryan ^a   Rader, Daniel J ^a,c  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b Mitsuke City Hospital   (Japan)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

atherosclerosis; high density lipoproteins

Indexed keywords

APOLIPOPROTEIN A2; HIGH DENSITY LIPOPROTEIN; TRACER;

ADULT; ARTICLE; FEMALE; HUMAN; IODINATION; LIPID ANALYSIS; LIPID METABOLISM; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN METABOLISM; PROTEIN TRANSPORT;

APOLIPOPROTEIN A-I; APOLIPOPROTEIN A-II; CARBON ISOTOPES; CHOLESTEROL, HDL; HUMANS; IODINE RADIOISOTOPES; KINETICS; PHENYLALANINE;

EID: 0029670293     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Miller, N. E. 1987. Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis. Am. Heart J. 113: 589-97.
2. Gordon, D. J., and B. M. Rifkind. 1989. High-density lipoprotein-the clinical implications of recent studies. N. Engl. J. Med. 321: 1311-1316.
3. Brewer, H. B., Jr., and D. J. Rader. 1991. HDL: structure, function and metabolism. Prog. Lipid Res. 30: 139-144.
4. Stampfer, M. J., F. M. Sacks, S. Salvini, W. C. Willett, and C. H. Hennekens. 1991. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N. Engl. J. Med. 325: 373-381.
5. Coleman, M. P., T. J. A. Key, and D. Y. Wang. 1992. A prospective study of obesity, lipids, apolipoproteins and ischemic heart disease in women. Atherosclerosis. 92: 177-185.
6. Sigurdsson, G., A. Baldursdottir, H. Sigvaldason, U. Agnarsson, G. Thorgeirsson, and N. Sigfusson. 1992. Predictive value of apolipoproteins in a prospective survey of coronary artery disease in men. Am. J. Cardiol. 69: 1251-1254.
7. Mehrabian, M., J. H. Qiao, R. Hyman, D. Ruddle, C. Laughton, and A. J. Lusis. 1993. Influence of the apoA-II gene locus on HDL levels and fatty streak development in mice. Arterioscler. Thromb. 13: 1-10.
8. Warden, C. H., C. C. Hedrick, J. H. Qiao, L. W. Castllani, and A. J. Lusis. 1993. Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II. Science. 261: 469-472.
9. Schultz, J. R., J. G. Verstuyft, E. L. Gong, A. V. Nichols, and E. M. Rubin. 1993. Protein composition determines the anti-atherogenic properties of HDL in transgenic mice. Nature. 365: 762-764.
10. Schaefer, E. J., L. A. Zech, L. L. Jenkins, T. J. Bronzert, E. A. Rubalcaba, F. T. Lindgren, R. L. Aamodt, and H. B. Brewer, Jr. 1982. Human apolipoprotein A-I and A-II metabolism. J. Lipid Res. 23: 850-862.
11. Brinton, E. A., S. Eisenberg, and J. L. Breslow. 1989. Elevated high density lipoprotein cholesterol levels correlate with decreased apolipoprotein A-I and A-II fractional catabolic rate in women. J. Clin. Invest. 84: 262-269.
12. Gylling, H., G. L. Vega, and S. M. Grundy. 1992. Physiologic mechanisms for reduced apolipoprotein A-I concentrations associated with low levels of high density lipoprotein cholesterol in patients with normal plasma lipids. J. Lipid Res. 33: 1527-1539.
13. Cheung, M. C., and J. J. Albers. 1984. Characterization of lipoprotein particles isolated by immunoaffinity chromatography. Particles containing A-I and A-II and particles containing A-I but no A-II. J. Biol. Chem. 259: 12201-12209.
14. Rader, D. J., G. Castro, L. A. Zech, J. C. Fruchart, and H. B. Brewer, Jr. 1991. In vivo metabolism of apolipoprotein A-I on high density lipoprotein particles LpA-I and LpA-I, A-II. J. Lipid Res. 32: 1849-1859.
15. Ikewaki, K., L. A. Zech, M. Kindt, J. H. B. Brewer, and D. J. Rader. 1995. Apolipoprotein A-II production rate is a major factor regulating the distribution of apolipoprotein A-I among HDL subclasses LpA-I and LpA-I:A-II in normolipidemic humans. Arterioscler. Thromb. Vasc. Biol. 15: 306-312.
16. Cryer, D. R., T. Matsushima, J. B. Marsh, M. Yudkoff, P. M. Coates, and J. A. Cortner. 1986. Direct measurement of apolipoprotein B synthesis in human very low density lipoprotein using stable isotopes and mass spectrometry. J. Lipid Res. 27: 508-516.
17. Cohn, J. S., D. A. Wagner, S. D. Cohn, J. S. Millar, and E. J. Schaefer. 1990. Measurement of very low density and low density lipoprotein apolipoprotein (apo) B-100 and high density lipoprotein apoA-I production in human subjects using deuterated leucine. Effect of fasting and feeding. J. Clin. Invest. 85: 804-811.
18. Ikewaki, K., D. J. Rader, J. R. Schaefer, T. Fairwell, L. A. Zech, and H. B. Brewer, Jr. 1993. Evaluation of apoA-I kinetics in humans using simultaneous endogenous stable isotope and exogenous radiotracer methods. J. Lipid Res. 34: 2207-2215.
19. Rader, D. J., K. Ikewaki, N. Duverger, I. Feuerstein, L. A. Zech, W. Conner, and H. B. Brewer, Jr. 1993. Very low high-density lipoproteins without coronary atherosclerosis. Lancet. 342: 1455-1458.
20. Brewer, H. B., Jr., S. E. Lux, R. Ronan, and K. M. John. 1972. Amino acid sequence of human apoLp-Gln-II (apoA-II), an apolipoprotein isolated from the high-density lipoprotein complex. Proc. Natl. Acad. Sci. USA. 69: 1304-1308.
21. Havel, R. J., H. A. Eder, and J. H. Bragdon. 1955. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34: 1345-1353.
22. Schaefer, J. R., D. J. Rader, K. Ikewaki, T. Fairwell, L. A. Zech, M. R. Kindt, J. Davignon, R. E. Gregg, and H. B. Brewer, Jr. 1992. In vivo metabolism of apolipoprotein A-I in a patient with homozygous familial hypercholesterolemia. Arterioscler. Thromb. 12: 843-848.
23. Tangier and amino acid sequence of the propeptide. Biochem. Biophys. Res. Commun. 113: 934-940.
24. Schaefer, J. R., D. J. Rader, and H. B. Brewer, Jr. 1992. Investigation of lipoprotein kinetics using endogenous labeling with stable isotopes. Curr. Opin. Lipidol. 3: 227-232.
25. Cobelli, C., G. Toffolo, and D. M. Foster. 1992. Tracer-to-tracee ratio for analysis of stable isotope tracer data: link with radioactive kinetic formalism. Am. J. Physiol. 262: E968-E975.
26. Berman, M., and M. Weiss. 1978. SAAM Manual. DHEW Publ. No. (NIH). National Institutes of Health, Bethesda, MD. 180.
27. Knott, T. J., S. C. Wallis, M. E. Robertson, L. M. Priestly, M. Urdea, L. B. Rall, and J. Scott. 1985. The human apolipoprotein A-II gene: structural organization and sites of expression. Nucleic Acids Res. 13: 6387-6398.
28. Eggerman, T. L., J. M. Hoeg, M. S. Meng, A. Tombragel, D. Bojanovski, and H. B. Brewer, Jr. 1991. Differential tissue-specific expression of human apoA-I and apoA-II. J. Lipid Res. 32: 821-828.
29. Warnick, G. R., M. C. Cheung, and J. J. Albers. 1979. Comparison of current methods for high-density lipoprotein cholesterol quantitation. Clin. Chem. 25: 596-604.
30. Norum, R. A., J. B. Lakier, and S. Goldstein. 1982. Familial deficiency of apolipoprotein A-I and C-II and precocious coronary artery disease. N. Engl. J. Med. 306: 1513-1516.
31. Schaefer, E. J., W. H. Heaton, M. G. Wetzel, and H. B. Brewer, Jr. 1982. Plasma apolipoprotein A-I absence associated with a marked reduction of high density lipoproteins and premature coronary artery disease. Arteriosclerosis. 2: 16-26.
32. Deeb, S. S., K. Takata, R. L. Peng, G. Kajiyama, and J. J. Albers. 1990. A splice-junction mutation responsible for familial apolipoprotein A-II deficiency. Am. J. Hum. Genet. 46: 822-827.
33. Rubin, E. M., R. M. Krauss, E. A. Spangler, J. G. Verstuyft, and S. M. Clift. 1991. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein A-I. Nature. 353: 265-267.
34. Vega, G. L., and S. M. Grundy. 1982. Metabolism of apolipoproteins A-I and A-II in man: methods, kinetic models, and turnover rates. In Lipoprotein Kinetics and Modeling. M. Berman, S. M. Grundy, and B. V. Howards, editors. Academic Press Inc., New York, NY. 397-407.
35. Schaefer, E. J., and J. M. Ordovas. 1986. Metabolism of apolipoprotein A-I, A-II, and A-IV. Methods Enzymol. 129: 420-443.
36. Rader, D. J., K. Ikewaki, N. Duverger, H. Schmidt, H. Pritchard, J. Frohlich, M. Clerc, D. Marie-France, T. Fairwell, L. Zech, S. Santamarina-Fojo, and H. B. Brewer, Jr. 1994. Markedly accelerated catabolism of apolipoprotein A-II (apoA-II) and high density lipoproteins containing apoA-II in classic lecithin:cholesterol acyltransferase deficiency and fish-eye disease. J. Clin. Invest. 93: 321-330.
37. Osborne, J. C., Jr., E. J. Schaefer, G. M. Powell, N. S. Lee, and L. A. Zech. 1984. Molecular properties of radioiodinated apolipoprotein A-I. J. Biol. Chem. 259: 347-353.
38. Brewer, H. B., Jr., R. Ronan, M. Meng, and C. Bishop. 1986. Isolation and characterization of apolipoprotein A-I, A-II, and A-IV. Methods Enzymol. 129: 223-246.
39. Ikewaki, K., D. J. Rader, L. A. Zech, and H. B. Brewer, Jr. 1994. Abnormal in vivo metabolism of apolipoproteins A-I and E in patients with abetalipoproteinemia; implications for the roles of apolipoproteins B and E in HDL metabolism. J. Lipid Res. 35: 1809-1819.
40. Beltz, W. F., Y. A. Kesaniemi, N. H. Miller, W. R. Fisher, S. M. Grundy, and L. A. Zech. 1990. Studies on the metabolism of apolipoprotein B in hypertriglyceridemic subjects using simultaneous administration of tritiated leucine and radioiodinated very low density lipoprotein. J. Lipid Res. 31: 361-374.
41. Zech, L. A., E. J. Schaefer, T. J. Bronzen, R. L. Aamodt, and H. B. Brewer, Jr. 1983. Metabolism of human apolipoprotein A-I and A-II: compartmental models. J. Lipid Res. 24: 60-71.
42. Fisher, W. R., V. Venkatakrishnan, L. A. Zech, C. M. Hall, L. L. Kilgore, P. W. Stacpoole, M. R. Diffenderfer, K. E. Friday, A. E. Sumner, and J. B. Marsh. 1995. Kinetic evidence for both a fast and a slow secretory pathway for apolipoprotein A-I in humans. J. Lipid Res. 36: 1618-1628.